3,3',5-triiodothyronamine has been researched along with Thyrotoxicosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bianchini, A; Bizzarri, G; Graziano, FM; Guglielmi, R; Pacella, CM; Palma, E; Papini, E; Petrucci, L; Poggi, M; Rinaldi, R; Toscano, V | 1 |
1 other study(ies) available for 3,3',5-triiodothyronamine and Thyrotoxicosis
Article | Year |
---|---|
Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy.
Topics: Administration, Cutaneous; Cost-Benefit Analysis; Cysts; Ethanol; Health Care Costs; Humans; Injections; Predictive Value of Tests; Prognosis; Thyroid Diseases; Thyroid Nodule; Thyrotoxicosis; Thyrotropin; Thyroxine; Treatment Outcome; Triiodothyronine | 2004 |